All SEC Filings :: Ligand Pharmaceuticals Incorporated (LGND)

Filter Filings:

Date	Form	Description	Docs	XBRL	Pages
01/27/22	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			5
01/25/22	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			5
01/14/22	8-K	Current report filing			4
11/17/21	4	Statement of changes in beneficial ownership of securities			2
11/12/21	4	Statement of changes in beneficial ownership of securities			2
11/12/21	4	Statement of changes in beneficial ownership of securities			2
11/09/21	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-31.1 EX-31.2 EX-32.1			44
11/09/21	8-K	Current report filing Related Documents EX-99.1			16
10/12/21	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			5
08/16/21	8-K	Current report filing			5